Substance Use Treatment and Recovery Team (START) for Opioid Use Disorder

Cedars Sinai Medical Center, Los Angeles, CA
Opioid Use Disorder+1 More ConditionsSubstance Use Treatment and Recovery Team (START) - Behavioral
All Sexes

Study Summary

This trial is testing whether a collaborative care team can increase the use of two interventions - medication for opioid use disorder and discharge planning for those with opioid use disorder - and improve linkage to follow-up care.

Eligible Conditions
  • Opioid Use Disorder

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: 30 days

30 days
Any post-discharge MOUD utilization
Linkage to follow-up OUD care
Past 30-day number of days with any opioid use
Post-discharge outpatient medical care
Day 7
In-hospital initiation of MOUD therapy
OUD-specific discharge plan

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Usual Care
1 of 2
Substance Use Treatment and Recovery Team (START)
1 of 2

Active Control

414 Total Participants · 2 Treatment Groups

Primary Treatment: Substance Use Treatment and Recovery Team (START) · No Placebo Group · N/A

Usual CareNoIntervention Group · 1 Intervention: Usual Care · Intervention Types:
Substance Use Treatment and Recovery Team (START)
ActiveComparator Group · 1 Intervention: Substance Use Treatment and Recovery Team (START) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 30 days

Who is running the clinical trial?

University of PittsburghOTHER
1,647 Previous Clinical Trials
16,311,235 Total Patients Enrolled
Cedars-Sinai Medical CenterLead Sponsor
470 Previous Clinical Trials
155,426 Total Patients Enrolled
128 Previous Clinical Trials
500,281 Total Patients Enrolled
University of New MexicoOTHER
347 Previous Clinical Trials
3,538,994 Total Patients Enrolled
Baystate HealthOTHER
5 Previous Clinical Trials
52,482 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
227 Previous Clinical Trials
362,202 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,305 Previous Clinical Trials
2,022,667 Total Patients Enrolled
Stanford UniversityOTHER
2,222 Previous Clinical Trials
34,904,183 Total Patients Enrolled
National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
39,326 Total Patients Enrolled
Allison J Ober, PhDPrincipal InvestigatorRAND
1 Previous Clinical Trials
88 Total Patients Enrolled
Itai Danovitch, MDPrincipal InvestigatorCedars-Sinai Medical Center
2 Previous Clinical Trials
103 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You speak English or Spanish as your main language.

Frequently Asked Questions

Is the recruitment process currently open for participants in this research?

"Correct. The information present on attests that this trial, which was initially posted on November 11th 2021, is currently recruiting for 414 individuals from 3 distinct medical centres." - Anonymous Online Contributor

Unverified Answer

How many participants are there in the current clinical trial?

"A total of 414 qualified individuals must join this medical trial. Patricipants can enlist from the University of New Mexico Hospital in Albuquerque, NM or Baystate Medical Center located in Springfield, MA." - Anonymous Online Contributor

Unverified Answer

What are the primary goals this clinical experiment seeks to accomplish?

"This 30-day clinical trial will primarily measure the rate of MOUD therapy initiation in hospital. Secondary objectives focus on OUD-specific discharge plans, post-discharge MOUD use and outpatients medical care within a month after leaving the hospital." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.